| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0073 | 0.9 |